Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Gastric Cancer
Metadata
Title
Docetaxel: its role in current and future treatments for advanced gastric cancer
Authors
Masahiko Nishiyama
Satoru Wada
Publication date
01-10-2009
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 3/2009
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-009-0521-z

Other articles of this Issue 3/2009

Gastric Cancer 3/2009 Go to the issue

Original Article

Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer

Case Report

Metastatic gastric tumor from renal cell carcinoma

Technical Note

Intraabdominal Roux-en-Y reconstruction with a novel stapling technique after laparoscopic distal gastrectomy

Original Article

Validation of the pepsinogen test method for gastric cancer screening using a follow-up study

Original Article

Pilot study to assess the safety of local lidocaine injections during endoscopic submucosal dissection for early gastric cancer

Editorial

Can an intramucosal undifferentiated-type gastric cancer become a candidate for endoscopic submucosal resection?

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits